Scientists uncover “genomic tug of war” that influences chemotherapy’s effectiveness

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine’s effects or become resistant over time.

TDR’s Top 5 Psychedelic Developments For The Week Of June 12

Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of June 12. Aside from presenting a synopsis of events, we provide

June 17, 2023

Drug for Sexual Desire Disorder in Women Works in Men, Too

SAN ANTONIO — A drug approved for hypoactive sexual desire disorder (HSDD) in premenopausal women also improved sexual dysfunction in some men, according to a

May 8, 2024

New method provides a more accurate way to predict dementia up to nine years before diagnosis

Researchers at Queen Mary University of London have developed a new method for predicting dementia with over 80% accuracy and up to nine years before

June 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.